Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement. Agreement and Plan of Merger On January 19, 2026, RAPT Therapeutics, Inc., a Delaware corporation (the “ Company ” o
of this report, including Exhibit 99.1 attached hereto, is furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed “filed” for purposes of Section 1
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 2.1 Agreement and Plan of Merger, dated as of January 19, 2026, by and among RAPT The